Display options
Share it on
Full text links
American Society for Clinical Investigation Free PMC Article

J Clin Invest. 1990 Aug;86(2):524-30. doi: 10.1172/JCI114739.

Molecular analysis of insertion/deletion mutations in protein 4.1 in elliptocytosis. II. Determination of molecular genetic origins of rearrangements.

The Journal of clinical investigation

J Conboy, S Marchesi, R Kim, P Agre, Y W Kan, N Mohandas

Affiliations

  1. Department of Laboratory Medicine, University of California, San Francisco 94143.

PMID: 2384598 PMCID: PMC296755 DOI: 10.1172/JCI114739
Free PMC Article

Abstract

Protein 4.1 is an approximately 80-kD structural protein in the membrane skeleton which underlies and supports the erythrocyte plasma membrane. The preceding companion paper presents a biochemical study of two abnormal protein 4.1 species from individuals with the red blood cell disorder, hereditary elliptocytosis. These variants, "protein 4.1(68/65)" and "protein 4.1(95)," have altered molecular weights due to internal deletions and duplications apparently localized around the spectrin-actin binding domain. Here we use polymerase chain reaction (PCR) techniques to clone and sequence the corresponding mutant reticulocyte mRNAs, and correlate the deletion/duplication end points with exon boundaries of the gene. Protein 4.1(68/65) mRNA lacks sequences encoding the functionally important spectrin-actin binding domain due to a 240 nucleotide (nt) deletion spanning the codons for Lys407-Gly486. Protein 4.1(95) mRNA encodes a protein with two spectrin-actin binding domains by virtue of a 369 nt duplication of codons for Lys407-Gln529. These deletions and duplications correspond to gene rearrangements involving three exons encoding 21, 59, and 43 amino acids, respectively. The duplicated 21 amino acid exon in the 4.1(95) gene retains its proper tissue-specific expression pattern, being spliced into reticulocyte 4.1 mRNA and out of lymphocyte 4.1 mRNA.

Similar articles

References

  1. Proc Natl Acad Sci U S A. 1977 Jul;74(7):3047-51 - PubMed
  2. Australas Ann Med. 1965 May;14:162-6 - PubMed
  3. J Biol Chem. 1984 Apr 10;259(7):4603-8 - PubMed
  4. Nature. 1984 Sep 13-19;311(5982):177-80 - PubMed
  5. Blood. 1985 Jan;65(1):46-51 - PubMed
  6. Science. 1986 Sep 5;233(4768):1076-8 - PubMed
  7. N Engl J Med. 1986 Sep 11;315(11):680-5 - PubMed
  8. Proc Natl Acad Sci U S A. 1986 Dec;83(24):9512-6 - PubMed
  9. Cell. 1987 Mar 13;48(5):827-35 - PubMed
  10. Proc Natl Acad Sci U S A. 1988 Jun;85(11):3713-7 - PubMed
  11. Blood. 1988 Jul;72(1):287-93 - PubMed
  12. Genomics. 1988 Feb;2(2):101-8 - PubMed
  13. Genomics. 1988 Feb;2(2):109-14 - PubMed
  14. Proc Natl Acad Sci U S A. 1988 Dec;85(23):9062-5 - PubMed
  15. Blood. 1988 Dec;72(6):1926-9 - PubMed
  16. J Biol Chem. 1989 Mar 5;264(7):3773-80 - PubMed
  17. Am J Hum Genet. 1989 Sep;45(3):368-72 - PubMed
  18. J Clin Invest. 1990 Aug;86(2):516-23 - PubMed
  19. J Clin Invest. 1981 Aug;68(2):454-60 - PubMed

Substances

MeSH terms

Publication Types

Grant support

LinkOut - more resources